AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25705872
Drug: 8 weeks
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 8 weeks nicotine patch treatment
Trial: 25705872
Drug: 24 weeks
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 24 weeks nicotine patch treatment
Trial: 26284723
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (8 weeks)
Trial: 22945761
Drug: Bazedoxifene (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bazedoxifene (20 or 40 mg)
Trial: 18201586
Drug: IV iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV iron supplementation (1 g IV iron sucrose administered as a 100 mg dose at each of 10 consecutive HD sessions)
Trial: 15288482
Drug: Interferon alpha
RxNorm normalized name: Interferon alpha-2a
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alpha 2a 3MIU thrice weekly with ribavirin 800-1,000 mg/day
Trial: 15288482
Drug: Interferon alpha
RxNorm normalized name: Interferon alpha-2a
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alpha 2a 3MIU daily plus amantadine 200 mg/day with ribavirin 800-1,000 mg/day
Trial: 11713358
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment for purulent sputum (5 or 10 days)
Trial: 11713358
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose inhaled steroid (fluticasone) for mucoid sputum (14 days)
Trial: 23506344
Drug: Human fibroblast-derived
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human fibroblast-derived dermal substitute (HFDS) plus four-layer compression therapy
Trial: 15114104
Drug: Histidine-tryptophan-ketoglutarate (HTK)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histidine-tryptophan-ketoglutarate (HTK) solution
Trial: 11575413
Drug: Lorazepam followed
RxNorm normalized name: Lorazepam
DrugBank: Lorazepam (DB00186)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lorazepam followed by midazolam (fentanyl 10-15 microg kg(‐1) and midazolam 0.05-0.075 mg kg(‐1) intraoperatively and a midazolam infusion for 3 h postoperatively)
Trial: 7527161
Drug: Calcium antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium antagonists (verapamil, nifedipine, verapamil+nifedipine)
Trial: 9494064
Drug: Pantoprazole 40
RxNorm normalized name: pantoprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 40 mg (steady state)
Trial: 9494064
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg (steady state)
Trial: 9494064
Drug: Biological in
RxNorm normalized name: COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological in vitro experiments with pantoprazole
Trial: 30554193
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplement of 4,000 IU daily for 3 years
Trial: 16595246
Drug: Alternate day
RxNorm normalized name: Alternaria alternata
DrugBank: Alternaria alternata (DB10424)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternate day triptorelin administration
Trial: 16595246
Drug: Daily triptorelin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily triptorelin administration
Trial: 16424845
Drug: Insulin-enriched warm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-enriched warm blood cardioplegia (IWBC) (10 UI/L)
Trial: 8528638
Drug: Standard postoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard postoperative radiation therapy or chemotherapy (control group)
Trial: 6775300
Drug: Nitroglycerin microcapsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin microcapsule preparation 2.5 mg
Trial: 27693759
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care with pediatrician's recommendation to visit parks and written resources (park prescription)
Trial: 17342879
Drug: Low dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dairy meal (80 mg Ca+2)
Trial: 1595918
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl (1, 2, or 4 micrograms/kg)
Trial: 1595918
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (epidural)
Trial: 10352397
Drug: Placebo (vehicle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (vehicle injection)
Trial: 8748889
Drug: Daflon 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daflon 500 mg (1 tablet daily)
Trial: 8748889
Drug: Daflon 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daflon 500 mg (4 tablets daily)
Trial: 8748889
Drug: Daflon 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daflon 500 mg (2 tablets daily)
Trial: 6163573
Drug: Terbutaline (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (5 mg, two tablets)
Trial: 1524161
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 300 mg daily
Trial: 12559533
Drug: Ticlopidine 2
RxNorm normalized name: ticlopidine 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine 2 x 250 mg daily
Trial: 11850161
Drug: Piperacillin/tazobactam (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin/tazobactam (2 g/0.5 g/q8h)
Trial: 11850161
Drug: Imipenem/cilastatin (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipenem/cilastatin (0.5 g/0.5 g/q8h)
Trial: 21048536
Drug: Steroid group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid group (n=54)
Trial: 21048536
Drug: Steroid-free immunosuppression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-free immunosuppression
Trial: 21048536
Drug: Steroid bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid bolus therapy
Trial: 17932357
Drug: Ibuprofen use
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen use (yes)
Trial: 16320746
Drug: Drug (group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug (group C)
Trial: 16320746
Drug: Electroacupuncture plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture plus drug (group E)
Trial: 11922399
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered twice daily for 21 days
Trial: 8311269
Drug: Fentanyl 5
RxNorm normalized name: fentanyl 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 5 micrograms/kg combined with thiopental 3 mg/kg, maintained with isoflurane and fentanyl 0.02 microgram.kg‐1.min‐1
Trial: 8311269
Drug: Ketamine 2
RxNorm normalized name: esketamine 28 mg nasal spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 2 mg/kg combined with thiopental 3 mg/kg, maintained with isoflurane and ketamine 20 micrograms.kg‐1.min‐1
Trial: 8311269
Drug: Thiopental 5
RxNorm normalized name: thiopental 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental 5 mg/kg, maintained with isoflurane only
Trial: 5303551
Drug: Unbuffered aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unbuffered aspirin ingestion with alcohol
Trial: 27455604
Drug: Standard diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard diet plus two drinks per day containing 4 g inulin, 4 mg menthol, and 2 mg pyridoxine for 2 weeks
Trial: 15578008
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of nefazodone and CBASP
Trial: 10430731
Drug: Inhaled low-molecular-weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled low-molecular-weight heparin (enoxaparin) 2 mg/kg
Trial: 7985890
Drug: Levothyroxine (thyroid‐stimulating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levothyroxine (thyroid‐stimulating hormone level, < 0.3 mU/L)
Trial: 7985890
Drug: Potassium iodide
RxNorm normalized name: Potassium Iodide
DrugBank: Potassium Iodide (DB06715)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Potassium iodide (2 mg every 2 weeks)
Trial: 6778352
Drug: Assisted ventilation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Assisted ventilation during mask inhalation anesthetic techniques
Trial: 26296850
Drug: Dark chocolate
RxNorm normalized name: Ensure Original Dark Chocolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dark chocolate (49 g/day) during reduced snack consumption
Trial: 25108751
Drug: Chiropractic flexion-distraction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chiropractic flexion-distraction manipulation (8 treatments)
Trial: 25108751
Drug: Chiropractic flexion-distraction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chiropractic flexion-distraction manipulation (18 treatments)
Trial: 19608997
Drug: Thalidomide (100-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide (100-200 mg daily for up to 2 years)
Trial: 15354209
Drug: IM862 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IM862 (20 mg intranasally three times daily for 8 weeks)
Trial: 23359969
Drug: Suxiao Jiuxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suxiao Jiuxin Pill (SJP) and Western medicine
Trial: 12017410
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR 300 mg/d
Trial: 2171046
Drug: Peptide histidine
RxNorm normalized name: Histidine
DrugBank: Histidine (DB00117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Peptide histidine valine (PHV) infusion
Trial: 25059694
Drug: Treatment after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment after neurologic recovery
Trial: 21216083
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) for three years
Trial: 18812629
Drug: Melatonin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (5 mg 30 min prior to ASA)
Trial: 18812629
Drug: L-tryptophan (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-tryptophan (0.5 g 30 min prior to ASA)
Trial: 18812629
Drug: Aspirin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (2 x 1 g daily)
Trial: 15883439
Drug: Step I
RxNorm normalized name: Bexxar Dosimetric Step Iodine I-131 Tositumomab Solution for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Step I diet supplemented with soy food (SFD; 50 mg isoflavones/d)
Trial: 1720478
Drug: Isradipine (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (1.25 mg or 2.5 mg twice daily)
Trial: 1720478
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of isradipine and captopril
Trial: 7326194
Drug: Corynebacterium parvum
RxNorm normalized name: Corynebacterium parvum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corynebacterium parvum (CP) 2 mg injection
Trial: 22858517
Drug: 10-day concomitant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day concomitant therapy comprising esomeprazole 40 mg, amoxicillin 1000 mg, clarithromycin 500 mg, and metronidazole 500 mg, all bid
Trial: 22858517
Drug: 10-day standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day standard triple therapy comprising esomeprazole 40 mg, amoxicillin 1000 mg, and clarithromycin 500 mg, all bid
Trial: 14991092
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical treatment plus CPAP
Trial: 11574419
Drug: Caffeine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (5 mg/kg body wt)
Trial: 9535249
Drug: PFP/PFP vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PFP/PFP vaccine
Trial: 7912767
Drug: Daily enteric-coated
RxNorm normalized name: lipase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily enteric-coated aspirin 300 mg
Trial: 3281173
Drug: Fenfluramine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenfluramine (60 mg p.o.)
Trial: 3281173
Drug: Arginine infusion
RxNorm normalized name: Arginine
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Arginine infusion (25 g i.v. for 30 min)
Trial: 1286524
Drug: Cabergoline 0.125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabergoline 0.125 mg twice weekly
Trial: 1286524
Drug: Cabergoline 0.5
RxNorm normalized name: cabergoline 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabergoline 0.5 mg twice weekly
Trial: 4064569
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CCK‐like peptide, caerulein, and secretin
Trial: 31905205
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (PosiFlush®, group A)
Trial: 31905205
Drug: Heparin (Fibrilin®,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (Fibrilin®, group B)
Trial: 17589949
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline injection (saline group)
Trial: 17589949
Drug: Submucosal saline‐epinephrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Submucosal saline‐epinephrine injection (epinephrine group)
Trial: 12175402
Drug: Saline injection
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline injection into the periprostatic nerve plexus
Trial: 28394933
Drug: Atorvastatin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (80 mg+40 mg)
Trial: 11094106
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of rizatriptan for three attacks and placebo for one attack
Trial: 8382710
Drug: Clomipramine and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine and maprotiline treatment
Trial: 3786347
Drug: 0.695 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.695 g/kg ethanol
Trial: 6814355
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g of cefuroxime
Trial: 6814355
Drug: 4.8 x
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.8 x 10(6) U of aqueous procaine penicillin G intramuscularly and 1.0 g of probenecid
Trial: 27436274
Drug: Intensive diabetes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive diabetes therapy
Trial: 27436274
Drug: Conventional diabetes
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional diabetes therapy
Trial: 28507269
Drug: r‐tPA+low‐dose argatroban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r‐tPA+low‐dose argatroban (100 μg/kg bolus followed by infusion of 1 μg/kg per minute for 48 hours)
Trial: 28507269
Drug: r‐tPA+high‐dose argatroban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r‐tPA+high‐dose argatroban (100 μg/kg bolus followed by infusion of 3 μg/kg per minute for 48 hours)
Trial: 28507269
Drug: r‐tPA+low‐dose or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r‐tPA+low‐dose or high‐dose argatroban
Trial: 28507269
Drug: r‐tPA+low‐dose argatroban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r‐tPA+low‐dose argatroban
Trial: 28507269
Drug: r‐tPA+high‐dose argatroban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r‐tPA+high‐dose argatroban
Trial: 25891339
Drug: Heparin-lidocaine combination
RxNorm normalized name: heparin, combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-lidocaine combination
Trial: 9246979
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of contraceptive pills
Trial: 7906700
Drug: Contrast condition
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contrast condition (CC)
Trial: 27026043
Drug: Atorvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (40 mg/day) + Interferon β-1a (30 μg/week)
Trial: 27026043
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Interferon β-1a 30 μg/week)
Trial: 24325987
Drug: Methylprednisolone acetate
RxNorm normalized name: methylprednisolone acetate
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone acetate 40 mg with lidocaine 1% (total volume 1 ml)
Trial: 15726658
Drug: Placebo (IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (IV and oral)
Trial: 12657843
Drug: Conservative fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative fluid management (1 ml/kg/h during surgery, total 9.5 ml/kg/h)
Trial: 12657843
Drug: Aggressive fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive fluid management (8 ml/kg/h during surgery)
Trial: 6384617
Drug: Corinfar (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corinfar (40 mg daily)
Trial: 6384617
Drug: Isoptin (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoptin (240 mg daily)
Trial: 30747547
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (800 μg every 4 hours, three doses)
Trial: 30747547
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol (800 μg every 4 hours, three doses)
Trial: 26091686
Drug: 80 kVp
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 kVp with 30 mL of 270 mg I/mL contrast material and iterative reconstruction (IR)
Trial: 26091686
Drug: 100 kVp
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 kVp with 60 mL of 370 mg I/mL contrast material and filtered back projection
Trial: 22777367
Drug: Uterosacral vault
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uterosacral vault suspension with pelvic floor muscle training
Trial: 22777367
Drug: Uterosacral vault
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uterosacral vault suspension without pelvic floor muscle training
Trial: 12010583
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (6 g/d, 3 g EPA+DHA)
Trial: 12010583
Drug: Olive oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oil (placebo, 6 g/d)
Trial: 9536924
Drug: Intravenous lactate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous lactate
Trial: 8587284
Drug: H.E.L.P. system
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H.E.L.P. system
Trial: 31603121
Drug: Yoga +
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Yoga + standard antiemetic therapy
Trial: 23987791
Drug: Standard antiemetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antiemetic therapy alone
Trial: 23095710
Drug: Dexmedetomidine 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 1.0 µg•kg(‐1)
Trial: 21764136
Drug: DEX implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DEX implant 0.7 mg (n = 341)
Trial: 21764136
Drug: DEX implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DEX implant 0.35 mg (n = 412)
Trial: 12412825
Drug: Tilidine 50
RxNorm normalized name: tilidine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tilidine 50 mg intravenously
Trial: 12412825
Drug: Tilidine 50
RxNorm normalized name: tilidine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tilidine 50 mg orally
Trial: 12412825
Drug: Nortilidine 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nortilidine 10 mg intravenously
Trial: 9584558
Drug: Anti-emetic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-emetic therapy
Trial: 3327931
Drug: Captopril (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (25 mg twice daily)
Trial: 183790
Drug: Corticotrophin-(1-23)-tricosipeptide-amide (Acethropan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticotrophin-(1-23)-tricosipeptide-amide (Acethropan S) at a dosage of 0.5 mg
Trial: 17926610
Drug: New Bian-stone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New Bian-stone therapy
Trial: 18082208
Drug: Daily cotrimoxazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily cotrimoxazole
Trial: 1489026
Drug: Extradural infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extradural infusion of lignocaine 0.75% after an initial dose of 10 ml of lignocaine 1.5%
Trial: 1489026
Drug: Extradural infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extradural infusion of bupivacaine 0.125% after an initial dose of 10 ml of bupivacaine 0.25%
Trial: 30536638
Drug: Golimumab (subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Golimumab (subcutaneous administration)